TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
16,962
|
22,828
|
21,768 |
| Financial expenses |
178
|
72
|
1 |
| Earnings before taxes |
504
|
7,586
|
11,131 |
| EBITDA |
211
|
7,322
|
11,006 |
| Total assets |
8,381
|
16,666
|
16,073 |
| Current assets |
7,420
|
15,750
|
15,360 |
| Current liabilities |
4,010
|
7,324
|
4,824 |
| Equity capital |
3,623
|
8,731
|
10,849 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
20
|
17
|
11 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.2%
|
52.4%
|
67.5% |
| Turnover per employee |
848
|
1,343
|
1,979 |
| Profit as a percentage of turnover |
3.0%
|
33.2%
|
51.1% |
| Return on assets (ROA) |
8.1%
|
45.9%
|
69.3% |
| Current ratio |
185.0%
|
215.0%
|
318.4% |
| Return on equity (ROE) |
13.9%
|
86.9%
|
102.6% |
| Change turnover |
-5,090
|
996
|
6,804 |
| Change turnover % |
-23%
|
5%
|
45% |
| Chg. No. of employees |
3
|
6
|
5 |
| Chg. No. of employees % |
18%
|
55%
|
83% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.